Overview

Gender

male

Investor Type

Investment Partner

Patrick Heron is the Board Director at VentiRX Pharmaceuticals.

Mr. Heron became a General Partner with the onset of FH V (2005), having been a partner in Frazier Healthcare IV (2001).

Mr. Heron focuses on biotechnology and growth equity opportunities. Mr. Heron joined Frazier Healthcare in 1999 and founded QuatRx Pharmaceuticals, an in-licensor of early-stage clinical development compounds, with its core management team in late 2000. He also led the opening of Frazier Healthcare's Palo Alto office in the summer of 2003.

Mr. Heron currently serves on the boards of Avera Pharmaceuticals, Cerexa, Chimerix, Informed Medical Communications, Panomics, QuatRx Pharmaceuticals and Trubion Pharmaceuticals.

Prior to joining Frazier Healthcare, Mr. Heron helped develop McKinsey & Co.'s West Coast biotechnology consulting practice after starting his career working with large pharmaceutical clients on the East Coast. His projects included corporate strategy, M&A, product launch, sales force optimization, corporate partnering and research prioritization.

Prior to joining McKinsey, Mr. Heron also worked with Massachusetts General Hospital in evaluating spin-off opportunities and with Cetus Corporation.

He was a Morehead Scholar at the University of North Carolina at Chapel Hill and holds an M.B.A. from Harvard Business School.